
Conference Coverage
about 1 month ago
B-ALL Data Reinforce Push for Risk-Tailored Careabout 1 month ago
Isatuximab OBI Cuts Infusion Reactions: Xavier Leleu, MD, PhDabout 1 month ago
Acalabrutinib-Venetoclax Combos Improve QOL, Safety by Age in CLLabout 1 month ago
Tec-Dara Closes Survival Gap in High-Risk MM: Rahul Banerjee, MDLatest Content

Shorts










Center on Health Equity & Access
All News

A researcher explains why cardiac diagnoses, not all-cause mortality, are the most reliable finding in her vaccine-safety study.

A randomized crossover trial found dose-dependent driving impairment from THC edibles at blood concentrations below common per se limits.

An infectious disease specialist discusses HIV prevention barriers facing Black women and how long-acting options and education can close gaps.

Ropeginterferon alfa-2b-njft is expected to be available immediately.

Irritants, cleaning products, and mites tracked with SHE in 56,978 Dutch adults, although the exposure tool was built for occupational asthma.

A cardiovascular researcher explains why her team compared cardiac risks of COVID-19 infection and vaccination head-to-head.

Experts discuss what SCAN Health Plan's new Medicare Advantage (MA) partnership with Costco could mean for beneficiaries, competition, and costs.

Ninety-six percent of the study population also had confirmed chronic traumatic encephalopathy on autopsy.

Poor cardiovascular health, especially high BMI and poor sleep, is linked to a substantially higher risk of overactive bladder, new data show.

A VESALIUS-CV analysis found a 20% reduction in all-cause death with evolocumab in patients without prior MI or stroke, emerging after 1.5 years.

































